• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22570425).
  
• Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323Valfs*19; Zygosity=Homozygous (PubMed=22570425).
  
• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=22570425).
  

PubMed=21097691; DOI=10.1158/1078-0432.CCR-10-1931
Sciuscio D., Diserens A.-C., van Dommelen K., Martinet D., Jones G., Janzer R.-C., Pollo C., Hamou M.-F., Kaina B., Stupp R., Levivier M., Hegi M.E.
Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres.
Clin. Cancer Res. 17:255-266(2011)

PubMed=22570425; DOI=10.1093/neuonc/nos072; PMCID=PMC3367844
Bady P., Diserens A.-C., Castella V., Kalt S., Heinimann K., Hamou M.-F., Delorenzi M., Hegi M.E.
DNA fingerprinting of glioma cell lines and considerations on similarity measurements.
Neuro-oncol. 14:701-711(2012)

PubMed=25622821; DOI=10.1186/s13059-015-0583-7; PMCID=PMC4342872
Kurscheid S., Bady P., Sciuscio D., Samarzija I., Shay T., Vassallo I., Van Criekinge W., Daniel R.T., van den Bent M.J., Marosi C., Weller M., Mason W.P., Domany E., Stupp R., Delorenzi M., Hegi M.E.
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.
Genome Biol. 16:16.1-16.15(2015)

PubMed=25772239; DOI=10.1038/onc.2015.61
Vassallo I., Zinn P.O., Lai M., Rajakannu P., Hamou M.-F., Hegi M.E.
WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Oncogene 35:12-21(2016)

PubMed=27717037; DOI=10.1002/nbm.3610
Porcari P., Hegi M.E., Lei H.-X., Hamou M.-F., Vassallo I., Capuani S., Gruetter R., Mlynarik V.
Early detection of human glioma sphere xenografts in mouse brain using diffusion MRI at 14.1 T.
NMR Biomed. 29:1577-1589(2016)